{"id":850793,"date":"2025-05-14T07:04:53","date_gmt":"2025-05-14T11:04:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/"},"modified":"2025-05-14T07:04:53","modified_gmt":"2025-05-14T11:04:53","slug":"ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/","title":{"rendered":"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">JUPITER, Fla., May  14, 2025  (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand\u2019s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions.<\/p>\n<p align=\"justify\">\u201cRinging the Nasdaq Opening Bell marks an exciting milestone in our company\u2019s history. Over the past few years, we have made significant progress in transforming Ligand into a profitable and infrastructure-light organization focused on acquiring and generating royalties from a diverse portfolio of biopharmaceutical products,\u201d said Todd Davis, CEO of Ligand. \u201cLooking ahead, we remain committed to building on the momentum we\u2019ve achieved over the past two years, supporting our partners in developing breakthrough medicines for patients, and creating long-term value for our shareholders.\u201d<\/p>\n<p align=\"justify\">The live broadcast of the Nasdaq Opening Bell ceremony will begin at\u00a09:15 a.m. Eastern Time and will be available at\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qtqtZmYY3Jlan1OvIKyP7mOoLM2aljlVnZLKAlQjZQ0G2E42BhDVnhhFv8IdeJfFtgf8JQiKddBfC7QnnC6KgK_eexT36zwpNnmTRJNUvxtr2mz9PPxzo-zO0P2bPf4JGm61ovIRPS5ldojjKk3a2IT1dF4pyXAJ0akiIb5lmgMnk9A_nWG1i1aIRyfhbZZm\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.nasdaq.com\/marketsite\/bell-ringing-ceremony<\/a><\/u>.<\/p>\n<p align=\"justify\">\n        <strong>About Ligand Pharmaceuticals<\/strong><br \/>\n        <br \/>Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner. Our business model is based on funding programs in mid- to late-stage drug development in return for economic rights, purchasing royalty rights in development stage or commercial biopharmaceutical products and licensing our technology to help partners discover and develop medicines. We partner with other pharmaceutical companies to attempt to leverage what they do best (late-stage development, regulatory management and commercialization) in order to generate our revenue. We operate two infrastructure-light royalty generating technology IP platform technologies. Our Captisol\u00ae platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our NITRICIL\u2122 platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a broad range of indications. We have established multiple alliances, licenses and other business relationships with the world\u2019s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter International. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uwSAsoebOyg9N7toz7p9iICe_qrWOxGrcqfCmn9rW7ALrghGMviAy-bHz8ij8QJawwwNiz4dsDRKyk0znW9zNg==\" rel=\"nofollow\" target=\"_blank\"><u>www.ligand.com<\/u><\/a>. Follow Ligand on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5HCrJoiqGgsXqhhrzndBjp3Mh8Oi56U22nViDVY0yboG_Ck2fdcfwbbtAnp3Cl5vVCUf9_XczKH_jXmT3jzEng==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y4_0w5N-u0MNfK_XV1zgRGkvZirknlocToeFpqq7X-y8ZMTHCFRebxhQE5l21SyTOCGfSxTZRFaJ_YFbwuEcT1MtEnP_Oaowt4P0SP0KGxQK5OCylfBqOSQ5blNz4NqP\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p align=\"justify\">We use our investor relations website and X as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Investors should monitor our website and our X account, in addition to following our press releases, SEC filings, public conference calls and webcasts.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong><br \/>\n        <br \/>Investors:<br \/>Melanie Herman<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=71wn2RTO8zIzu7TazCYjue0875pdHzmh7KwVAxxO2rAITSqLSGpm74kJb0MK6tCwLrpU80tLzXVqVCPTeDB2WWa0LlHzhGOj83GQdgPPAoXpc6_Y1G_O8drZxh8KkZcZsHCVeIUNZKngjzG2yWdFFjTfLiFrc6QJnAm-6cq0LmeO3c6-TcA_raW5GLftnm_T3USwvDpLcQmrVjV85dvhcqzimlyqvy4lbZePe31iL94f4KeRUpSq-aLBnUZQ059CkP7Z_zAh6i7m7lwfD-parA==\" rel=\"nofollow\" target=\"_blank\">investors@ligand.com<\/a><br \/>(858) 550-7761<\/p>\n<p>Media: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Kellie Walsh<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BqKlUveSaDL2gedIxxeLFkTDP006L9Nx9RPlgNWTBgut0_cu-IWpvVw3igxIDbYoJE_Hu8GrTOrr2TmPRKqve5jwKL9JScO3hKkDmicmvp0cwhpy1ftIXHssYOn95R7s7X-21NcY87guoMRqyIZQesKwHZ0ewLt5NJ7zLSVSGWln6eFwgTZuI7L6nKnxs3jvGNBdkLwlOxe2qzSDBRAuXW-sDNuXmayvwfumg4Qkcpc=\" rel=\"nofollow\" target=\"_blank\">media@ligand.com<\/a><br \/>(914) 315-6072<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Nzc1Yzg5ZTUtMDVlNi00NWEwLTllZDctMmYxZjE3YWZlMzFmLTEwMTgxMzctMjAyNS0wNS0xNC1lbg==\/tiny\/Ligand-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand\u2019s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions. \u201cRinging the Nasdaq Opening Bell marks an exciting milestone in our company\u2019s history. Over the past few years, we have made significant progress in transforming Ligand into a profitable and infrastructure-light organization focused on acquiring and generating royalties from a diverse portfolio of biopharmaceutical products,\u201d said Todd Davis, CEO of Ligand. \u201cLooking ahead, we remain committed to building on the momentum we\u2019ve &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ligand to Ring the Nasdaq Opening Bell on May 19, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-850793","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand\u2019s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions. \u201cRinging the Nasdaq Opening Bell marks an exciting milestone in our company\u2019s history. Over the past few years, we have made significant progress in transforming Ligand into a profitable and infrastructure-light organization focused on acquiring and generating royalties from a diverse portfolio of biopharmaceutical products,\u201d said Todd Davis, CEO of Ligand. \u201cLooking ahead, we remain committed to building on the momentum we\u2019ve &hellip; Continue reading &quot;Ligand to Ring the Nasdaq Opening Bell on May 19, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-14T11:04:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025\",\"datePublished\":\"2025-05-14T11:04:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/\"},\"wordCount\":488,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/\",\"name\":\"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=\",\"datePublished\":\"2025-05-14T11:04:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/","og_locale":"en_US","og_type":"article","og_title":"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - Market Newsdesk","og_description":"JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) &#8212; Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand\u2019s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions. \u201cRinging the Nasdaq Opening Bell marks an exciting milestone in our company\u2019s history. Over the past few years, we have made significant progress in transforming Ligand into a profitable and infrastructure-light organization focused on acquiring and generating royalties from a diverse portfolio of biopharmaceutical products,\u201d said Todd Davis, CEO of Ligand. \u201cLooking ahead, we remain committed to building on the momentum we\u2019ve &hellip; Continue reading \"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-14T11:04:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025","datePublished":"2025-05-14T11:04:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/"},"wordCount":488,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/","name":"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=","datePublished":"2025-05-14T11:04:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ1MDcxMCM2OTM5MzA3IzIwMDY1NjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligand-to-ring-the-nasdaq-opening-bell-on-may-19-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ligand to Ring the Nasdaq Opening Bell on May 19, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/850793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=850793"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/850793\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=850793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=850793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=850793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}